Seroquel is not a MAOI. Seroquel (quetiapine) is an atypical antipsychotic, which is a completely different class of medication from monoamine oxidase inhibitors. The two drugs work through distinct mechanisms in the brain and are prescribed for different purposes.
How Seroquel Works
Seroquel belongs to a chemical class called dibenzothiazepine derivatives. It works by blocking several types of receptors on brain cells, including receptors for serotonin, dopamine, histamine, and adrenaline. By occupying these receptors, Seroquel changes how these chemical messengers signal between neurons. It is FDA-approved to treat schizophrenia, bipolar disorder, and as an add-on treatment for major depression.
The key distinction is that Seroquel blocks receptors. It sits on the surface of brain cells and prevents certain chemicals from activating them. It does not change the amount of those chemicals floating around in the brain.
How MAOIs Work
MAOIs take a fundamentally different approach. Instead of blocking receptors, they block an enzyme called monoamine oxidase, which is responsible for breaking down serotonin, dopamine, and norepinephrine after those chemicals have done their job. When this enzyme is blocked, levels of all three neurotransmitters rise in the brain. MAOIs were the first type of antidepressant ever developed and include medications like phenelzine and tranylcypromine.
The practical difference matters: Seroquel changes how the brain responds to its chemical signals, while MAOIs increase the overall supply of those signals. These are two very different pharmacological strategies.
Can Seroquel Be Taken With a MAOI?
This is likely the real concern behind the search. The combination of Seroquel and a MAOI is not standard practice, but it has been used in cases of treatment-resistant depression under close medical supervision.
One of the biggest risks when combining medications with MAOIs is serotonin syndrome, a potentially dangerous condition caused by too much serotonin activity in the brain. Because Seroquel blocks serotonin receptors rather than increasing serotonin levels, the combination would not be expected to trigger serotonin syndrome. Published case reports largely support this. In a review of cases where quetiapine was combined with MAOIs, serotonin syndrome did not occur in three out of four patients studied.
One reported case involved a 72-year-old woman on phenelzine (a MAOI) who developed rigidity, tremor, and muscle jerks after her Seroquel dose was increased. However, the researchers noted this reaction may not have been serotonin syndrome at all. It could have been a side effect of Seroquel itself (called extrapyramidal symptoms), worsened by a drug interaction that raised Seroquel levels in her blood. Phenelzine can slow the breakdown of Seroquel in the liver, effectively making a modest dose act like a higher one.
Orthostatic hypotension, a sudden drop in blood pressure when standing up, is a more practical concern. Both Seroquel and MAOIs can lower blood pressure on their own, and combining them increases that risk. In at least one documented case involving both drug classes, orthostasis was a significant problem.
Why the Distinction Matters
MAOIs carry a long list of dangerous interactions precisely because they raise levels of multiple neurotransmitters at once. Combining a MAOI with another drug that also raises serotonin (like certain antidepressants or even some over-the-counter cold medications) can push serotonin to dangerous levels. Seroquel does not raise serotonin. It blocks serotonin receptors, which is pharmacologically the opposite effect. That is why Seroquel is not classified alongside MAOIs and does not carry the same interaction profile.
Among atypical antipsychotics, the one that does raise some concern for serotonin-related interactions with MAOIs is ziprasidone, because it has additional properties that block the reabsorption of serotonin and norepinephrine, somewhat like an antidepressant. Seroquel does not share this property.